Shipeng Li
Capital Medical University
15 Papers
69 Citations
Shipeng Li is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Comparative analysis of the virulence characteristics of epidemic methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from Chinese children: ST59 MRSA highly expresses core gene-encoded toxin.
Shipeng Li,Jing Sun, Distinguished Professor,Jianzhong Zhang,Xiangmei Li,Xiaoxia Tao,Lijuan Wang,Mingjiao Sun,Yingchao Liu,Juan Li,Yanhong Qiao,Sangjie Yu,Kaihu Yao,Yonghong Yang,X. Shen +13 more
TL;DR: This study indicated that ST59 was the predominant clone in the MRSA isolates obtained from Chinese children and might have stronger pathogenic potential and might be related to the expressions of PSMα and RNAIII and infection invasiveness.
35
Prevalence and invasiveness of community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis
TL;DR: The prevalence of CA-MRSA in MRSA infection varied with area and population, and no difference in the ability to cause invasive infections was found between CA- and HA- MRSA.
25
Clinical and molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus infections in Chinese neonates.
Shipeng Li,Xue Ning,Wenqi Song,Fang Dong,Yaojie Zheng,Qiang Chen,Yanhong Qiao,Juan Li,Lijuan Wang,Qun Wang,Liqin Yue,Aihua Wang,Sangjie Yu,Kaihu Yao,Yonghong Yang,Xuzhuang Shen +15 more
TL;DR: It was showed that neonatal CA‐MRSA infections in China readily become invasive, involve multiple organs, and are often accompanied by complications, and the SCCmec V clone may be more pathogenic than the S CCmecVIa clone.
11
Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China
Junmei Zhang,Li Sun,XinWei Shi,Shipeng Li,Cuihua Liu,Xiaoqing Li,Meiping Lu,Xiaohua Tan,Wanzhen Guan,Guomin Li,Ping Liu,Laifeng Li +11 more
TL;DR: It is suggested that tofacitinib therapy exerted a certain effect on skin manifestations, muscle manifestations, interstitial lung disease (ILD), calcinosis, as well as downgrade of medication.
8
Efficiency of tofacitinib in refractory interstitial lung disease among anti-MDA5 positive juvenile dermatomyositis patients.
Y. Xue,Junmei Zhang,Jianghong Deng,Weiying Kuang,Jiang Wang,Xiaohua Tan,Chao-Jun Li,Shipeng Li,Laifeng Li +8 more
TL;DR: It is the first case series research summarising the efficiency of tofacitinib on antiMDA5 positive JDM patients with refractory ILD, and the nonresponded group tended to show higher serum ferritin, serum IgG level and higher proportion of total T cells, CD4+T cells and CD8-T cells.
7